Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix.
Ludwig, M
Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix. [electronic resource] - Fertility and sterility Jan 2001 - 18-22 p. digital
Publication Type: Journal Article; Multicenter Study
0015-0282
10.1016/s0015-0282(00)01632-0 doi
Adult
Cohort Studies
Congenital Abnormalities--epidemiology
Embryo Transfer
Europe--epidemiology
Female
Fertility Agents, Female--adverse effects
Fertilization in Vitro
Fetal Death--epidemiology
Follow-Up Studies
Germany--epidemiology
Gonadotropin-Releasing Hormone--adverse effects
Health
Hormone Antagonists--adverse effects
Humans
Infant
Infant, Newborn
Ovary--drug effects
Pregnancy
Pregnancy Complications--epidemiology
Twins
Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix. [electronic resource] - Fertility and sterility Jan 2001 - 18-22 p. digital
Publication Type: Journal Article; Multicenter Study
0015-0282
10.1016/s0015-0282(00)01632-0 doi
Adult
Cohort Studies
Congenital Abnormalities--epidemiology
Embryo Transfer
Europe--epidemiology
Female
Fertility Agents, Female--adverse effects
Fertilization in Vitro
Fetal Death--epidemiology
Follow-Up Studies
Germany--epidemiology
Gonadotropin-Releasing Hormone--adverse effects
Health
Hormone Antagonists--adverse effects
Humans
Infant
Infant, Newborn
Ovary--drug effects
Pregnancy
Pregnancy Complications--epidemiology
Twins